Inhibikase Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $542k | 323k | 1.68 |
| 2024-12-31 | $15k | 4.5k | 3.25 |
| 2024-09-30 | $69 | 53 | 1.30 |
| 2024-06-30 | $51 | 42 | 1.21 |
| 2023-12-31 | $79 | 62 | 1.27 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation